Health Vidya

Eulexin® capsules are indicated for use in combination with LHRH-agonists for the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate. Treatment with Eulexin® capsules and the goserelin acetate implant should start eight weeks prior to initiating radiation therapy and continue during radiation therapy. To achieve benefit from treatment, Eulexin® capsules should be initiated with the LHRH-agonist and continued until progression.